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Diagnostic Performance of Breast MRI in the Evaluation of
Contralateral Breast in Patients with Diagnosed Breast Cancer
Shaista Afzal Saeed1*, Imrana Masroor1, Madiha Beg1, Romana Idrees2
Abstract
Aims: The purpose of our study was to evaluate the diagnostic performance of breast magnetic resonance
imaging (MRI) in the evaluation of contralateral breast in patients with diagnosed breast cancer. A secondary
objective was to determine accuracy of breast MRI in diagnosing multi-focal and multicentric lesions in the
ipsilateral breast. Materials and Methods: Using a non-probability convenience sampling technique, patients
with histopathologically diagnosed breast cancer with MRI of breast performed to exclude additional lesions were
included. MRI findings were correlated with histopathology. In addition, follow-up imaging with mammography
and ultrasound was also assessed for establishing stability of negative findings and for the detected of benign
lesions. Results: Out of 157 MRI breast conducted during the period of 2008 to 2013, 49 were performed for
patients with diagnosed breast cancer. The sample comprised of all females with mean age 50.7±11.0 years. The
patient follow-up imaging was available for a period of 2-5 years. The sensitivity, specificity, and positive and
negative predictive values of MRI in the detection of multifocal/multicenteric lesions was 85.7%, 88.8%, 60%
and 96.6% respectively and for the detection of lesions in the contralateral breast were 100%, 97%, 83.3% and
100% respectively. Conclusions: Our study highlights the diagnostic performance and the added value of MRI
in the detection of multifocal /multicenteric and contralateral malignant lesions. In patients with diagnosed
breast cancer having dense breast parenchyma and with infiltrating lobular carcinoma as the index lesion MRI
is particularly useful with excellent negative predictive value in the exclusion of additional malignant foci in the
ipsilateral and contralateral breasts.
Keywords: MRI breast - multicenteric - multifocal - bilateral breast cancer
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Introduction

Breast cancer is the most commonly diagnosed cancer
in women with significant cancer related mortality in the
developed and developing countries (Yusuf et al., 2013)
Patients with unilateral breast cancer have an added
risk of cancer in the contra lateral breast with prevalence
of 1-4% (Jobsen et al., 2003). These patients have a
higher rate of distant metastasis and unfavorable disease
specific survival as compared to those with unilateral
breast tumour (Heron et al., 2000). It is important to
diagnose contra lateral breast cancer at the time of
initial diagnosis as the actuarial survival rates at 5 years
is lower for patients with bilateral synchronous breast
cancer (64.4%) as compared to patients with unilateral
disease (75.8%). (Polednak et al., 2003). Screening
mammography has resulted in early diagnosis of breast
cancer which has led to more conservative surgical
approach. Since undetected malignant foci frequently
results in relapses after breast conservative surgery as
reported in 3-19% of patients, (Goethem et al., 2004) this
surgical option should be utilized after the exclusion of
undetected multifocal /multicenteric disease in addition
to any contralateral synchronous cancer (Esserman et

al., 1999). The sensitivity of screening mammography
is reduced in women with heterogeneously dense /dense
breast parenchyma but whole breast ultrasounds is useful
in the detection of mammographically and clinically occult
ipsilateral and contra lateral breast cancer (Moon ,2002;
Beysebayev, 2014) with reasonably accurate estimation of
invasive cancer but often underestimates the component
of ductal carcinoma in situ. (DCIS) (Satake et al., 2000).
Breast Magnetic resonance imaging (MRI) has
emerged as an important adjunctive tool and multiple
studies have shown increased detection of tumor foci
not identified on mammography or ultrasound. Multiple
diagnostic and screening indications for MRI breast
have been discussed and suggested by American college
of radiology (ACR 2013) An additional occult cancer
in contralateral breast detected on MRI ranges from
3-24% and this subsequently alters the management plan
(Liberman, 2003; Kowalchik, 2012).
The purpose of our study was to evaluate the diagnostic
performance of breast MRI in the evaluation of contra
lateral breast in patients with diagnosed breast cancer.
The secondary objective was to evaluate accuracy of
breast MRI in diagnosing multi focal and multicenteric
lesions in the ipsilateral breast.

Radiology, 2Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi, Pakistan *For correspondence: shaista.
afzal@aku.edu
1

Asian Pacific Journal of Cancer Prevention, Vol 16, 2015

7607

Shaista Afzal Saeed et al

Materials and Methods
This cross sectional analytical study was conducted
in the Radiology department AKUH after obtaining
exemption (2862-Rad-ERC-13) from the hospital ethical
review committee.
All MRI breast done during the period of January 2008
to December 2013 were included. Using non-probability
convenience sampling technique, all of the patents with
histopathologically diagnosed breast cancer and with MRI
of breast done to exclude additional lesions were included.
These patients had no clinical, mammographic or breast
ultrasound evidence of occult additional breast lesions.
Patients were excluded if the MRI breast was done for
other indications like for assessment of BIRADS 3 lesions,
implant evaluations, screening, neoadjuvant response
evaluation, differentiation of scar versus recurrence.
Patients were also excluded if no follow-up imaging was
available.
Patient’s mammography and ultrasound done at the
time of breast cancer diagnosis were also assessed. The
index lesion was defined as the first lesion detected by
patient as palpable lump or first detected at imaging or
the lesion assigned as highest BIRADS category when
more than one lesions were detected at initial workup.
(Kim et al., 2014). The MRI findings were correlated
with histopathology. In addition follow-up imaging i.e.
mammography and ultrasound were also assessed for
establishing stability of negative findings and for the
detected benign lesions. For the purpose of reporting and
data analysis, the multi focal and multicenteric cancers
were taken as one group, For the study breast cancer on
contralateral side was defined as cancer diagnosed in both
breast concurrently or within a period of three months of
diagnosis of the first lesion (Jobsen et al., 2003).
Statistical analysis plan
Data was entered and analyzed in SPSS 20.0 version.
The data comprised of age of the patient, mammographic
density, prior mammography and ultrasound findings,
the breast involved, histopathology of index lesions
and the MRI detected lesions in the ipsilateral breast
i.e. multifocal/multicenteric lesions and in contralateral
breast. In addition development of malignancy on follow
up imaging was also noted. Means and Standard deviation
were computed for quantitative variable like age and
proportions reported for qualitative variable. Sensitivity,
specificity, positive and negative predictive values with
95%confidence interval were computed for MRI breast
in the evaluation of contra lateral and ipsilateral breast in
patients with diagnosed breast cancer. Diagnostic accuracy
of breast MRI was also calculated.
Reported sensitivity of breast MRI for the detection
of breast carcinoma is 92% (Hillman et al., 2012) with
confidence interval of 95%, bound on error of 8%, the
calculated sample size was N=45.
Breast MRI technique
All cases underwent a breast MRI in a 1.5 tesla unit.
The conventional departmental breast MRI protocol was
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carried out using breast coil with patient in prone position.
The field of view was 300-340 mm and slice thickness
of 4 mm.
Prior to post contrast images axial TRIM, T1 and T2
weighted images were obtained. In addition diffusion
weighted images and sagittal T2 fat saturated images
also obtained. This is followed by dynamic post contrast
images in the axial plane. Vascular access obtained with
a cannula for the administration of Gadolinium using
power injector at a dose of 0.1 mmol/kg of body weight
followed by 20 ml of saline flush. The dynamic image
sequence was repeated six times with 30 sec interval and
the images were obtained in the axial plane. The delayed
post contrast image were obtained in coronal sections. Post
processing included subtracted images, 2D and 3D MIP
(maximum intensity projection) reconstructions, wash in
and washout maps and kinetic curve analysis.
The images were interpreted by radiologist with
more than 5 years’ experience in breast imaging on soft
copy using picture archiving and communication system
(PACS) with provision of manual window setting and
parameters optimization. The radiologist was provided
with patient clinical history and all available imaging like
mammograms and ultrasound of breast. The breast lesion
was categorized using Breast imaging reporting and data
system (BIRADS) MR Lexicon.
The MRI detected lesions were classified in accordance
to that described in literature (Liberman et al., 2002)
based on T2 signal intensity, mass or non-mass like
enhancement, features of a mass like margins, shape,
enhancement and kinetic curve analysis
For all MRI detected suspicious findings second look
sonography was performed to determine if a correlate
of the lesion is evident and to assess for feasibility of
ultrasound guided biopsy. The mammograms were
also reviewed to assess for presence of mammographic
correlate.
Patients follow up imaging ie mammography and
ultrasound were reviewed and any suspicious finding
recorded.
The mastectomy/ lumpectomy specimen was grossed
according to the standard criteria and representative
sections were submitted, five micron sections were cut
from paraffin embedded tissue blocks and were stained
with hematoxylin and eosin. The microscopic findings
were noted and reported by an experienced pathologist.
Where the need arise, immunohistochemical stains were
also performed. Reporting was done on a synoptic pattern
according to the College of American pathologist (CAP)
guidelines.

Results
Out of the 157 MRI breast done during the period
of 2008 to 2013, 49 were performed in patients with
diagnosed breast cancer. Four patients were post
unilateral mastectomy (duration post-surgery being 1 to
3 months) and MRI studies were done for the evaluation
of contralateral breast only.
The sample comprised of all female with mean age
50.7 +/-11.04 years. Age range was 46 years and minimum
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Table 1. Diagnostic Performance of MRI Breast for Evaluation of Multifocal/Multicenteric & Contralateral
Lesions
Type of Lesion

Sensitivity
(95% CI§)

Specificity
(95% CI§)

Multifocal / Multicentric lession 85.71% (0.42-0.99)
Contralateral Breast
100% (0.46-1¶)

* PPV
(95% CI§)

$
NPV
(95% CI§)

Accuracy

88.88% (0.73-0.96)
60% (0.27-0.86) 96.96% (0.82-0.99) 88.37%
97.73% (0.86-0.99 ) 83.33% (0.36-0.99)
100% (0.89-1¶) 97.96%

95% CI: 95% confidence interval; * PPV: Positive Predicative Value; $ NPV: Negative Predictive Value; (¶): CI insignificant as one of the cell
contains a “zero value”
§

Table 2. Table 2 : Comparison of previous studies for assessment of multifocal / multicentric & contralateral
malignant lesions by Breast MRI
Author

Publication Year

Liberman et al

2003

Pediconi et al

2007

Berg et al

Mameri et al

Duygulu et al
Afzal et al ~

Sample Size

Multifocal

70

20%

2004

120

30% **

2008

99

18.0%

49

12% **

2012
2015

164
68

Multicentric
lesions
4%

Contralateral lesions
5.0%
2.7%

4.2%

2.4%

29.0%

5.8%

4.4%

1.4%

0.7%

3.0%

10.0%

**: Authors did not demarcate between multifocal and multi centeric lesions; ~: Current study reports results

Figure 1. Dynamic Post Contrast Enhanced MRI
Showing Index Lesion in Right Breast with Multiple
Enhancing Foci Suggestive of Multifocal /Multicenteric
and Bilateral Disease. On second look ultrasound a well-

defined hypo echoic lesion correlated with the right breast
nodular enhancing lesion which on biopsy diagnosed as
fibroadenoma. No correlate seen on second look ultrasound for
the contralateral breast. No suspicious finding in left breast on
follow up imaging

and maximum were 26 and 71 years respectively. The
patient follow-up imaging was available for a period of
2 to 5 years.
Second look ultrasound performed to evaluate the 21
MRI detected suspicious findings in the ipsilateral (n=11)
and contralateral (n=10) breast. Ultrasound correlate was
identified for suspicious lesions presenting with mass like
enhancement in 13 (62%). Abnormal foci of enhancement
without an associated mass and measuring less than 5 mm
noted in 8 cases showed no corresponding sonographic
correlate and these patients on follow-up imaging were

Figure 2. Right Breast Multifocal Multicenteric Disease
(Arrows) on Dynamic Contrast Enhanced Scan. An
ultrasound correlate was detected for these lesions , which on
biopsy confirmed presence of multifocality /multicentericity

stable without any interval development.
Due to the nonexistence of a national screening
programme in our country the indication for initial
imaging in 69% of patients was palpable breast lump,
pain in 8%, and nipple discharge in 2%. In 20% of patients
the reason for initial imaging was as a part of general
medical checkup. The breast density on mammography
was heterogeneously dense in 45%, fibro glandular in
31% and dense in 20%.The breast parenchyma was fatty
on mammography in only 4%.
The size of the index lesion at the time of presentation
was from 1 to 2cm in 43% (n=21) followed by 2 to 5 cm
in 35 %(n=17). Less than 1cm index lesions were seen
in 14%. The size of the index lesion was more than 5 cm
in 8%.
The predominant histopathology of the primary /
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Figure 3. Dynamic Contrast Enhanced MRI Showing
Index Lesion in Right Breast. Suspicious lesion with rapid
enhancement and early washout on left side. On second look
ultrasound revealed ill defined hypoechoic lesion which on
subsequent biopsy was diagnosed as infiltrating ductal carcinoma
and confirmed presence of malignancy in contralateral breast

index breast lesions was infiltrating ductal carcinoma
61% followed by infiltrating lobular carcinoma in 22%.
The others were papillary carcinoma, mucinous carcinoma
and DCIS.
On the basis of MRI scan, suspicious findings detected
in the contralateral breast were confirmed to be malignant
in five patients; this comprised the true positive group.
Out of these two were invasive lobular carcinoma (ILC)
and one each of invasive ductal carcinoma (IDC), ductal
carcinoma in situ (DCIS) and papillary carcinoma. The
size of the index lesion in this group ranged from 1 to 5
cm. The size of the lesion in contralateral breast detected
on MRI was below 1.0 cm and no axillary lymph node
involvement was present.
The false positive MRI of contralateral breast on
histopathology was diagnosed as florid ductal hyperplasia,
papilloma, apocrine metaplasia, adenosis and fibrocystic
change.
The diagnostic performance of breast MRI for
detection of lesions in contralateral breast and in the
ipsilateral breast in the present study as shown in Table 1.

Discussion
Breast MRI is an expensive test, reported to have high
sensitivity (94-100%) but low specificity that ranges from
37-97% (Orel and Schnall, 2001). These factors restricts
its usage as a screening modality for the population and
hence it is utilized for limited indications like women with
genetic predisposition, strong family history /personal
history of breast cancer, women with lobular carcinoma
or atypia, etc (Tilanus-Linthorst et al., 2000). Analysis of
the MRI detected enhancing lesions in accordance to the
American college of Radiology breast imaging reporting
and data system (BIRADS) lexicon is an essential factor
in improving the diagnostic performance. (Abdulkareem,
2014).
In this retrospective study we evaluated the diagnostic
performance of breast MRI in the detection of an otherwise
occult contra lateral breast cancer in addition to multifocal
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/multicenteric lesions (Table 1). Additional cancer foci
that are histologically proven are reported in 21 to 63 %
of women with clinical diagnosis of localized cancer and
further confirmed by imaging (Houssami et al., 2008)
In this study cancer was detected in contralateral breast
in patients with diagnosed breast cancer in 10 % which
is in line with the various published reports in literature
(3% - 24%) (Lehman et al., 2007) In Asian population
however synchronous bilateral cancer ranges from 1.5 -2%
(Kim et al., 2012) which is much lower than our study.
The detection rate of multifocal /multicenteric lesions
in the present study is 12% and is in the range as stated
in previous studies i.e. 2.4 to 30 % (Berg et al., 2004;
Pediconi et al., 2007) (Table 2)
The breast cancer screening programme is non-existent
in our country and majority of patients present with
palpable tumors as is also evident in our study. In our
study 78% of our patients, the index lesion at the time of
presentation was in the range of 1 to 5 cm. Increase size
of index tumor is identified as a correlate for the increased
frequency of additional malignant foci in ipsilateral and
contralateral breast. (Moon et al., 2002)
In the present study the index and the contralateral
lesions showed similar histology in 80 % cases. (Liberman
et al., 2003) reports concordant histology in 67% of
women. Early age at initial diagnosis, family history
of breast cancer and a lobular histology have been
identified as risk factors associated with development
of contralateral breast cancer in women with a known
primary of breast. The two risk factors i.e. early age
at diagnosis and lobular histology is also noted in our
patients with synchronous bilateral breast cancer. (Chen
et al.,1999; Ji and Hemminki, 2007)
An important risk factor associated with breast cancer
is the mammographic density, the principal mechanism
likely to be masking rather than rapid tumor growth (Wang
et al., 2012). In such cases alternative imaging techniques
are likely to enhance detection of occult / additional cancer
(Boyd et al., 2007).
The specificity of MRI in the evaluation of contralateral
breast in our study is 97.7% and is at the higher side of
that reported in literature (37-97%). (Orel and Schnall ,
2001) The proposed reason for this is because sonographic
correlate was found in 62 % of the lesions detected on MRI.
The results are similar to the study by Kim et al which
reports detection of ultrasound correlates in 64% and out
of these 69% of lesions characterized as masses and 46%
as non-mass like enhancement on MRI (Demartini et al.,
2009) In the present study none of the enhancing foci
less than 5 mm had any ultrasound correlate on second
look ultrasound and in the absence of any correlate,
MRI was categorized as probably benign finding. All of
these patients were stable on follow-up imaging without
development of interval malignancy hence confirming
the benign nature of the enhancing foci. (Figure 1). In
keeping with multiple previous studies (Candelaria and
Fornage, 2011), more malignant lesions showed a second
look ultrasound correlate than benign lesions. (Figure 2
and 3) Based on the previous reports (Beran et al., 2005)
describing the lower probability of malignancy in MRI
detected lesions which are occult on ultrasound some sites
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mastectomy decisions. J surg oncol, 104, 741-5.
also recommend short term imaging follow up.
Beran L, Liang W, Nims T, Paquelet J, Sickle-Santanello B
Breast MRI although being highly sensitive but false
(2005). Correlation of targeted ultrasound with magnetic
negative findings do occur, mostly due to lack of apparent
resonance imaging abnormalities of the breast. Am J Surg,
mass as seen with DCIS and lobular carcinoma(Hillman
190, 592-4.
et al., 2012). The false negative cases mostly result from
Berg WA, Gutierrez L, NessAiver MS, et al (2004). Diagnostic
lack of enhancement of lesions or misinterpretation of
accuracy of mammography, clinical examination, US, and
enhancing lesion. (Millet et al., 2012). In the present
MR imaging in preoperative assessment of breast cancer.
study lack of enhancement of lesion being the cause of
Radiol, 233, 830-49.
false negative in the evaluation of multicenteric/multifocal
Beysebayev E, Tulebayev K, Meymanalyev T (2014). Breast
cancer diagnosis by mammography in Kazakhstan-staging
disease. There was no false negative case in the MRI
results of breast cancer with double reading. Asian Pac J
screening of contralateral breast in the present study
Cancer Prev, 16, 31-4.
which is also confirmed by stability of the findings on
Boyd NF, Guo H, Martin LJ, et al (2007). Mammographic
follow up imaging.
density and the risk and detection of breast cancer. N Engl
The sensitivity and NPV of MRI in the screening of
J Med, 356, 227-36.
contralateral breast for synchronous lesions is 100% in
Candelaria R, Fornage BD (2011). Second-look us examination
the present study. This information questions the value of
of MR-detected breast lesions. J Clin Ultrasound, 39, 115contralateral prophylactic mastectomies (Herrinton et al.,
21.
2005) and is expected to influence the decision making
Chen Y, Thompson W, Semenciw R, Mao Y (1999). Epidemiology
of contralateral breast cancer. Cancer Epidemiol Biomarkers
by women and breast surgeons regarding the surgical
Prev, 8, 855-61.
options. In addition it also results in lower rate of cancer
Cichon MA, Degnim AC, Visscher DW, Radisky DC (2010).
recurrence at follow up.
Microenvironmental influences that drive progression from
In comparison to contralateral breast, more false
benign breast disease to invasive breast cancer. J Mammary
positive cases were identified in the ipsilateral breast.
Gland Biol Neoplasia, 15, 389-97.
Our sample size is small and further studies with large
DeMartini WB, Eby PR, Peacock S, Lehman CD (2009). Utility
sample size are needed to explain this biological behavior
of targeted sonography for breast lesions that were suspicious
and micro environmental influences (Cichon et al,. 2010;
on MRI. AJR Am J Roentgenol, 192, 1128-34.
Yang et al., 2010).
Duygulu G, Oktay A, Bilgen IG, Kapkac M, Zekioglu O (2012).
The role of breast MRI in planning the surgical treatment of
Several limitations of the study were identified, One
breast cancer. Diagn Interv Radiol, 18, 460-7.
of these being small sample size and retrospective design.
Esserman L, Hylton N, Yassa L, et al (1999). Utility of magnetic
The non-availability of MRI guided biopsy instruments
resonance imaging in the management of breast cancer:
also added to the limitation of the study. But in the present
evidence for improved preoperative staging. J Clin Oncol,
study, second look ultrasound was performed for all MRI
17, 110-19.
detected lesions by radiologist interpreting the MRI
Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield
with more than 5 years of experience in breast imaging.
CM (2000). Bilateral breast carcinoma: risk factors and
Pathological confirmation for all the lesions could not be
outcomes for patients with synchronous and metachronous
obtained due to reason described above, but follow-up
disease. Cancer, 88, 2739-50.
Herrinton LJ, Barlow WE, Yu O, et al (2005). Efficacy of
imaging ranging from 2 to 5 years was available to confirm
prophylactic mastectomy in women with unilateral breast
the benign nature of MRI detected findings without an
cancer: a cancer research network project. J Clin Oncol,
ultrasound correlate. In the present study the impact of
23, 4275-86.
diagnosing additional malignant foci on the treatment and
Hillman BJ, Harms SE, Stevens G, et al (2012). Diagnostic
survival of patient are not evaluated.
performance of a dedicated 1.5-T breast MR imaging system.
Our study highlights the diagnostic performance and
Radiol, 265, 51-58.
the added value of contrast enhanced breast MRI in the
Houssami N, Ciatto S, Macaskill P, et al (2008). Accuracy and
detection of multifocal /multicenteric and contralateral
surgical impact of magnetic resonance imaging in breast
malignant lesions. In patients with diagnosed breast cancer
cancer staging: systematic review and meta-analysis in
detection of multifocal and multicentric cancer. J Clin
showing dense breast parenchyma on mammography and
Oncol, 26, 3248-58.
with infiltrating lobular carcinoma as index lesion MRI
Ji J, Hemminki K (2007). Risk for contralateral breast cancers
is particularly useful with excellent negative predictive
in a population covered by mammography: effects of family
value in the exclusion of additional malignant foci in the
history, age at diagnosis and histology. Breast Cancer Res
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